Literature DB >> 12191607

Designing bisubstrate analog inhibitors for protein kinases.

Keykavous Parang1, Philip A Cole.   

Abstract

Protein kinases play critical roles in signal transduction pathways by transmitting extracellular signals across the cell membrane to distant locations in the cytoplasm and the nucleus. The development of protein kinase inhibitors has been hindered by the broad overlapping substrate specificities exhibited by these enzymes. The design of bisubstrate analog inhibitors could provide for the enhancement of specificity and potency in protein kinase inhibition. Bisubstrate analog inhibitors form a special group of protein kinase inhibitors that mimic two natural substrates/ligands and that simultaneously associate with two regions of given kinases. Most bisubstrate analogs have been designed to mimic the phosphate donor (ATP) and the acceptor components (Ser-, Thr-, or Tyr-containing peptides). Recent studies have emphasized the importance of maintaining a specific distance between these two components to achieve potent inhibition. In this review, we present a discussion of the methods for designing protein kinase inhibitors by mechanism-based approaches. Emphasis is given to bivalent approaches, with an interpretation of what has been learned from more and less successful examples. Future challenges in this area are also highlighted.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12191607     DOI: 10.1016/s0163-7258(02)00184-5

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  18 in total

1.  Targeting diverse signaling interaction sites allows the rapid generation of bivalent kinase inhibitors.

Authors:  Zachary B Hill; B Gayani K Perera; Simeon S Andrews; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2011-12-22       Impact factor: 5.100

Review 2.  Small Molecule Inhibitors of Protein Arginine Methyltransferases.

Authors:  Hao Hu; Kun Qian; Meng-Chiao Ho; Y George Zheng
Journal:  Expert Opin Investig Drugs       Date:  2016-02-16       Impact factor: 6.206

3.  Probing the Plasticity in the Active Site of Protein N-terminal Methyltransferase 1 Using Bisubstrate Analogues.

Authors:  Dongxing Chen; Cheng Dong; Guangping Dong; Karthik Srinivasan; Jinrong Min; Nicholas Noinaj; Rong Huang
Journal:  J Med Chem       Date:  2020-07-16       Impact factor: 7.446

4.  Phenylalanine-Based Inactivator of AKT Kinase: Design, Synthesis, and Biological Evaluation.

Authors:  Thuy Nguyen; Robert A Coover; Jenson Verghese; Richard G Moran; Keith C Ellis
Journal:  ACS Med Chem Lett       Date:  2014-03-07       Impact factor: 4.345

Review 5.  Revitalizing antifolates through understanding mechanisms that govern susceptibility and resistance.

Authors:  Shannon Lynn Kordus; Anthony David Baughn
Journal:  Medchemcomm       Date:  2019-05-08       Impact factor: 3.597

6.  Bivalent inhibitors of the tyrosine kinases ABL and SRC: determinants of potency and selectivity.

Authors:  Zachary B Hill; B Gayani K Perera; Dustin J Maly
Journal:  Mol Biosyst       Date:  2010-11-09

7.  Structural insights into mis-regulation of protein kinase A in human tumors.

Authors:  Jonah Cheung; Christopher Ginter; Michael Cassidy; Matthew C Franklin; Michael J Rudolph; Nicolas Robine; Robert B Darnell; Wayne A Hendrickson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

8.  Non-peptidic substrate-mimetic inhibitors of Akt as potential anti-cancer agents.

Authors:  Katherine J Kayser-Bricker; Matthew P Glenn; Sang Hoon Lee; Said M Sebti; Jin Q Cheng; Andrew D Hamilton
Journal:  Bioorg Med Chem       Date:  2008-09-27       Impact factor: 3.641

9.  Comparative analysis of mutant tyrosine kinase chemical rescue.

Authors:  Kathryn E Muratore; Markus A Seeliger; Zhihong Wang; Dina Fomina; Johnathan Neiswinger; James J Havranek; David Baker; John Kuriyan; Philip A Cole
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

10.  Staurosporine tethered peptide ligands that target cAMP-dependent protein kinase (PKA): optimization and selectivity profiling.

Authors:  Carolyn D Shomin; Scott C Meyer; Indraneel Ghosh
Journal:  Bioorg Med Chem       Date:  2009-07-26       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.